Long-term outcomes of autoimmune pancreatitis: A multicentre, international analysis

Gut

Volumn 62, Issue 12, 2013, Pages 1771-1776

  Hart, Phil A ^a   Kamisawa, Terumi ^b   Brugge, William R ^c   Chung, Jae Bock ^d   Culver, Emma L ^e   Czakó, László ^f   Frulloni, Luca ^g   Go, Vay Liang W ^h   Gress, Thomas M ⁱ   Kim, Myung Hwan ^j   Kawa, Shigeyuki ^k   Lee, Kyu Taek ^l   Lerch, Markus M ^m   Liao, Wei Chih ⁿ   Löhr, Matthias ^o   Okazaki, Kazuichi ^p   Ryu, Ji Kon ^q   Schleinitz, Nicolas ^r   Shimizu, Kyoko ^s   Shimosegawa, Tooru ^t   Soetikno, Roy ^u   Webster, George ^v   Yadav, Dhiraj ^w   Zen, Yoh ^x   Chari, Suresh T ^a   more..

^a MAYO CLINIC   (United States)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Yonsei University   (South Korea)

^e JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^f UNIVERSITY OF SZEGED   (Hungary)

^g UNIVERSITY OF VERONA   (Italy)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ PHILIPPS UNIVERSITY MARBURG   (Germany)

^j University of Ulsan College of Medicine   (South Korea)

^k SHINSHU UNIVERSITY   (Japan)

^l Sungkyunkwan University   (South Korea)

^m UNIVERSITY MEDICINE GREIFSWALD   (Germany)

ⁿ NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^o KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^p KANSAI MEDICAL UNIVERSITY   (Japan)

^q Seoul National University   (South Korea)

^r AIX MARSEILLE UNIVERSITY   (France)

^s TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^t TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^u STANFORD UNIVERSITY   (United States)

^v UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^w UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^x KING S COLLEGE HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G4; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; STEROID;

ADULT; ARTICLE; AUTOIMMUNE PANCREATITIS; BILIARY STENT; CLINICAL FEATURE; CONSERVATIVE TREATMENT; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INTERNATIONAL COOPERATION; JAUNDICE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PANCREAS CANCER; PANCREAS DUCT STENOSIS; PANCREAS RESECTION; PRIORITY JOURNAL; REMISSION; SCLEROSING CHOLANGITIS;

AUTOIMMUNE DISEASE; PANCREATIC CANCER; PANCREATO-BILIARY DISORDERS;

ANTI-INFLAMMATORY AGENTS; AUTOIMMUNE DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATITIS, CHRONIC; PREDNISOLONE; RECURRENCE; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 84887443321     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-303617     Document Type: Article

References (18)

1. Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995;40:1561-8.
2. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732-8.
3. Notohara K, Burgart LJ, Yadav D, et al. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol 2003;27:1119-27.
4. Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology 2010;139:140-8; quiz e12-3.
5. Topazian M, Witzig TE, Smyrk TC, et al. Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2008;6:364-6.
6. Hart PA, Topazian MD, Witzig TE, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut 2013;62:1607-15.
7. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009;58:1504-7.
8. Sandanayake NS, Church NI, Chapman MH, et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2009;7:1089-96.
9. Zamboni G, Luttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Archiv 2004;445:552-63.
10. Ryu JK, Chung JB, Park SW, et al. Review of 67 patients with autoimmune pancreatitis in Korea: a multicenter nationwide study. Pancreas 2008;37:377-85.
11. Kamisawa T, Chari ST, Giday SA, et al. Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas 2011;40:809-14.
12. Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011;40:352-8.
13. Hirano K, Isogawa A, Tada M, et al. Long-Term Prognosis of Autoimmune Pancreatitis in Terms of Glucose Tolerance. Pancreas 2012;41:691-5.
14. Kamisawa T, Okazaki K, Kawa S, et al. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol 2010;45:471-7.
15. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008;134:706-15.
16. Raina A, Yadav D, Krasinskas AM, et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol 2009;104:2295-306.
17. Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993;328:1433-7.
18. Wang LW, Li ZS, Li SD, et al. Prevalence and clinical features of chronic pancreatitis in China: a retrospective multicenter analysis over 10 years. Pancreas 2009;38:248-54.